Hermetica Superfood Encyclopedia
The Short Answer
Cassia tora seeds contain anthraquinones—principally chrysophanol, emodin, aurantio-obtusin, and rhein—that exert antioxidant, hypolipidemic, and hepatoprotective effects through free-radical scavenging and modulation of lipid metabolism pathways. Aqueous seed extracts demonstrated 70% inhibition of benzo[a]pyrene-induced DNA damage in HepG2 human hepatoma cells at 1 mg/ml concentration, representing the strongest quantified hepatoprotective data currently available from laboratory studies.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordCassia tora benefits
Cassia tora — botanical close-up
Health Benefits
**Hepatoprotection**
Aqueous seed extracts reduced benzo[a]pyrene-induced DNA damage by 70% at 1 mg/ml in HepG2 hepatoma cells; anthraquinones including chrysophanol and emodin are attributed with antihepatotoxic activity by mitigating oxidative stress in liver tissue.
**Antioxidant Activity**: Ethanolic leaf extracts contain 106
8 ± 2.8 mg/g dry weight of flavonoids (quercetin equivalents), including quercetin, kaempferol, epicatechin, and rutin, which neutralize reactive oxygen species and reduce lipid peroxidation in preclinical models.
**Hypolipidemic Effects**
Anthraquinone constituents, particularly emodin and chrysophanol, have demonstrated lipid-lowering properties in animal studies by modulating hepatic cholesterol synthesis and enhancing bile acid excretion, though human clinical confirmation is absent.
**Anti-inflammatory Properties**
Polyphenols and flavonoids in leaf extracts exhibit anti-inflammatory activity by inhibiting pro-inflammatory mediator pathways; compounds such as apigenin and emodin are documented to suppress inflammatory signaling in preclinical assays.
**Larvicidal / Antiparasitic Activity**
Cassia tora seed extracts caused 100% mortality in Anopheles stephensi mosquito larvae at standard concentrations and 60% mortality at 0.3% concentration after 24-hour exposure, indicating potent antiplasmodial and insecticidal utility.
**Eye Health Support (Traditional)**
In Indonesian Jamu and Chinese traditional medicine, roasted seed preparations are used for eye disorders including conjunctivitis and blurred vision; chryso-obtusin and aurantio-obtusin are the anthraquinone constituents associated with this traditional application.
**Antiallergic and Cardioprotective Potential**
Flavonoid constituents demonstrate antiallergic, antiatherosclerotic, and antithrombogenic properties in cell-based studies, suggesting cardiovascular protective roles, though these remain unvalidated in clinical trials.
Origin & History
Natural habitat
Cassia tora is a pantropical annual legume native to South and Southeast Asia, thriving in disturbed soils, roadsides, and agricultural margins across India, Indonesia, China, and sub-Saharan Africa. It grows best in warm, humid climates with well-drained soils and is considered a pioneer weed species, requiring minimal cultivation intervention. In Indonesia, China (where it is known as Jue Ming Zi), and India, seeds and leaves are harvested seasonally for traditional medicinal preparations.
“Cassia tora has been documented in the Chinese Materia Medica under the name Jue Ming Zi ('seed that brightens vision') for over 2,000 years, where roasted seeds were prescribed in decoctions for eye disorders, headache, hypertension, and constipation attributable to liver heat. In Indonesian traditional medicine (Jamu), leaves and seeds form part of formulations for liver toning, skin conditions including ringworm, and eye inflammation, reflecting a parallel ethnobotanical tradition across maritime Southeast Asia. In Indian Ayurvedic and folk medicine, the plant is called Chakramard or Puwad and is used topically for fungal skin infections and internally as a mild laxative due to anthraquinone content. The seed's mild coffee-like roasted aroma when prepared as a decoction led to its use as a coffee substitute in parts of Africa and South Asia during periods of scarcity, further illustrating its broad ethnobotanical footprint.”Traditional Medicine
Scientific Research
The evidence base for Cassia tora consists almost entirely of in vitro cell-line studies, phytochemical characterization studies, and small animal experiments, with no peer-reviewed human randomized controlled trials identified in the current literature. Phytochemical studies have rigorously characterized flavonoid content across extraction methods (ethanolic: 106.8 mg/g; methanolic: 72.4 mg/g; aqueous: 30.4 mg/g quercetin equivalents) and documented anthraquinone profiles in seeds, lending moderate credibility to compositional claims. Larvicidal studies using Anopheles stephensi are among the best-controlled preclinical experiments, showing dose-dependent mortality (40% at 0.2%, 60% at 0.3%, 100% at standard concentration after 24 hours), but these do not translate directly to human therapeutic endpoints. Overall, the scientific evidence is at a preliminary preclinical stage; the ingredient's traditional use in Jamu and Chinese medicine provides ethnopharmacological plausibility, but clinical efficacy and safety in humans remain largely unestablished.
Preparation & Dosage
Traditional preparation
**Roasted Seeds (Traditional Decoction)**
3–9 g of roasted seeds simmered in water, as used in Chinese pharmacopoeia (Jue Ming Zi); taken as tea once or twice daily for eye and liver complaints
**Seed Powder (Oral)**
1–3 g per dose; no standardized clinical dose established
Traditional Jamu preparations use dried, ground seed powder at approximately .
**Ethanolic Leaf Extract**
Research extracts prepared at 0.1–0.4% concentrations (w/v); in vitro flavonoid-active concentrations range from 25–200 µg/ml, with no validated human equivalent dose.
**Aqueous Seed Extract**
1 mg/ml; optimal human dose has not been determined through pharmacokinetic studies
Laboratory hepatoprotective activity observed at .
**Standardization Note**
No commercially standardized supplement form (e.g., defined % chrysophanol or emodin) has been established; bioavailability of anthraquinones after oral ingestion is affected by gut microbiome metabolism and first-pass hepatic extraction.
**Timing**
Traditional preparations are typically consumed in the morning for eye complaints and with food for digestive/liver applications, though no clinical timing data exists.
Nutritional Profile
Cassia tora leaves contain approximately 11.25% crude protein and 28.00% crude fiber on a dry weight basis, with 17 amino acids identified including essential amino acids, making the leaf nutritionally significant as a forage supplement in resource-limited settings. Mineral content per 100 g dry leaf includes calcium (3.45 g), magnesium (0.85 g), potassium (0.75 g), and iron (0.25 g), contributing to micronutrient density. Primary phytochemicals include anthraquinones (chrysophanol, emodin, rhein, aurantio-obtusin, chryso-obtusin, 1-desmethylaurantio-obtusin), naphthopyrone glucosides (cassia side, rubrofusarin-6-o-β-gentiobioside, toralactone-9-o-β-D-gentiobioside), and flavonoids (quercetin, kaempferol, epicatechin, rutin) at concentrations up to 106.8 mg/g in ethanolic leaf extracts. Bioavailability of anthraquinone glycosides is limited until colonic bacterial hydrolysis liberates aglycone forms; fat-soluble anthraquinone aglycones exhibit moderate absorption, while polar flavonoid glycosides rely on intestinal glycosidase activity for uptake.
How It Works
Mechanism of Action
The primary anthraquinones in Cassia tora seeds—chrysophanol, emodin, rhein, aurantio-obtusin, and chryso-obtusin—exert antioxidant effects through direct free-radical scavenging and inhibition of lipid peroxidation cascades, with emodin also documented to modulate NF-κB inflammatory signaling and inhibit xanthine oxidase activity. Flavonoids including quercetin and kaempferol from leaf extracts chelate transition metals, upregulate endogenous antioxidant enzymes (superoxide dismutase, catalase), and inhibit cyclooxygenase-mediated eicosanoid synthesis, contributing to anti-inflammatory and antiatherosclerotic outcomes. Naphthopyrone glucosides from the seeds—cassia side, rubrofusarin-6-o-β-gentiobioside, and toralactone-9-o-β-D-gentiobioside—may contribute hepatoprotective effects by reducing genotoxic metabolite formation, as evidenced by comet-assay data showing 70% DNA-damage inhibition in HepG2 cells. Hypolipidemic activity is attributed to anthraquinone-mediated modulation of hepatic lipid metabolism, including enhancement of bile acid secretion and inhibition of HMG-CoA reductase-related pathways, though specific receptor binding constants in humans have not been characterized.
Clinical Evidence
No published human clinical trials with formal sample sizes, randomized designs, or pre-registered endpoints have been identified for Cassia tora supplementation. The most quantified laboratory finding is 70% inhibition of benzo[a]pyrene-induced DNA damage in HepG2 hepatoma cells at 1 mg/ml aqueous seed extract, which constitutes in vitro hepatoprotective evidence but cannot be extrapolated to clinical dosing or human outcomes without pharmacokinetic bridging studies. Hypolipidemic and anti-inflammatory claims derive from animal and cell-culture models, where effect sizes are notable but methodological translation to humans is uncertain due to differences in metabolism and bioavailability. Confidence in clinical benefit ratings must therefore remain low; practitioners relying on this ingredient do so primarily on the basis of traditional use and mechanistic plausibility rather than clinical efficacy data.
Safety & Interactions
Human safety data for Cassia tora supplementation is extremely limited, with no formal toxicology studies, maximum tolerated dose studies, or adverse event registries published in peer-reviewed literature for human subjects. Anthraquinone-containing plants as a class (including related Senna species) are associated with dose-dependent laxative effects, electrolyte imbalances with chronic use, and potential melanosis coli with prolonged anthraquinone ingestion; these class-effect risks are presumptively applicable to Cassia tora. Theoretical drug interactions include potentiation of anticoagulant therapy due to antithrombogenic flavonoids, additive effects with hepatically metabolized drugs via CYP450 modulation by emodin, and possible interference with antidiabetic medications given hypolipidemic anthraquinone activity. Cassia tora is contraindicated in pregnancy due to the stimulant laxative activity of anthraquinones and absence of safety data; lactating women and individuals with pre-existing inflammatory bowel disease, renal impairment, or chronic liver disease should avoid use until controlled safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Cassia tora L.Senna toraJue Ming ZiChakramardSicklepodFoetid CassiaPuwadKetepeng kecil
Frequently Asked Questions
What is Cassia tora used for in traditional medicine?
In Chinese traditional medicine, Cassia tora roasted seeds (Jue Ming Zi) are used in decoctions to treat eye disorders, headaches, hypertension, and constipation associated with liver heat. In Indonesian Jamu, seeds and leaves serve as a liver tonic and are applied for skin conditions including ringworm; the plant's chrysophanol and aurantio-obtusin anthraquinones are considered the primary active compounds responsible for these applications.
Does Cassia tora protect the liver?
Preclinical laboratory evidence supports hepatoprotective activity; an aqueous seed extract reduced benzo[a]pyrene-induced DNA damage by 70% at 1 mg/ml concentration in HepG2 human liver cancer cells, as measured by comet assay. However, no human clinical trials have confirmed liver-protective efficacy in vivo, so the hepatoprotective claim rests on in vitro data and traditional use rather than clinical proof.
What are the main active compounds in Cassia tora seeds?
The primary bioactive compounds in Cassia tora seeds are anthraquinones—chrysophanol, emodin, rhein, aurantio-obtusin, chryso-obtusin, and 1-desmethylaurantio-obtusin—alongside naphthopyrone glucosides including cassia side and rubrofusarin-6-o-β-gentiobioside. Flavonoids (quercetin, kaempferol, rutin, epicatechin) are most concentrated in the leaves, reaching up to 106.8 mg/g dry weight in ethanolic extracts.
Is Cassia tora safe to consume, and are there any side effects?
Formal human safety studies for Cassia tora have not been published, making a definitive safety profile impossible to establish. As an anthraquinone-containing plant, it shares class-level risks with Senna species, including laxative effects, electrolyte disturbances with chronic use, and potential drug interactions with anticoagulants and hepatically metabolized medications; use during pregnancy is contraindicated due to stimulant anthraquinone content.
What is the recommended dose of Cassia tora?
The Chinese pharmacopoeia tradition uses 3–9 g of roasted Cassia tora seeds as a daily decoction for eye and liver complaints, which represents the most historically grounded dosing guideline. No standardized clinical dose has been established through controlled human trials; research extracts have used concentrations of 25–200 µg/ml in cell studies and 0.2–1% in larvicidal experiments, but these experimental concentrations do not directly translate to human supplementation doses.
Does Cassia tora interact with liver medications or anticoagulants?
Cassia tora contains anthraquinones that may potentiate the effects of hepatic-metabolized drugs and anticoagulants like warfarin due to its hepatoprotective and antioxidant activity. Concurrent use with blood-thinning medications or medications metabolized by cytochrome P450 enzymes should be discussed with a healthcare provider to prevent adverse interactions. Limited clinical data exists on specific drug-herb interactions, making medical supervision important for patients on pharmaceutical liver treatments.
Is Cassia tora safe to use during pregnancy or while breastfeeding?
Cassia tora contains anthraquinone compounds historically used as laxatives, which may stimulate uterine contractions and are generally contraindicated during pregnancy. There is insufficient safety data on Cassia tora use during breastfeeding, making avoidance the prudent approach for pregnant and nursing women. Women planning pregnancy or currently pregnant should consult a healthcare provider before supplementing with this herb.
How does the bioavailability of Cassia tora seeds compare to leaf extracts?
Cassia tora seed extracts demonstrate superior hepatoprotective activity in vitro compared to leaf extracts, with aqueous seed preparations showing 70% reduction in oxidative DNA damage at therapeutic concentrations. Ethanolic leaf extracts contain high flavonoid content (106.8 mg/g dry weight) but may have lower bioavailability than concentrated seed extracts due to compound solubility differences. The choice between seed and leaf preparations depends on the desired therapeutic outcome—seeds for liver protection and leaves for general antioxidant support.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w cassia-tora-sicklepod-foetid-cassia curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
